BrightPath Biotherapeutics Co Ltd (4594)

Currency in JPY
39.0
+1.0(+2.63%)
Closed·
4594 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.039.0
52 wk Range
36.096.0
Key Statistics
Bid/Ask
38.00 / 39.00
Prev. Close
38
Open
38
Day's Range
37-39
52 wk Range
36-96
Volume
841.4K
Average Volume (3m)
1.43M
1-Year Change
-32.7586%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4594 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Nov 16, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

4594 Income Statement

Compare 4594 to Peers and Sector

Metrics to compare
4594
Peers
Sector
Relationship
P/E Ratio
−4.0x−6.6x−0.2x
PEG Ratio
−0.24−0.250.00
Price/Book
2.2x3.0x2.6x
Price / LTM Sales
62,831.7x10.9x2.7x
Upside (Analyst Target)
-112.2%66.0%
Fair Value Upside
Unlock20.6%10.8%Unlock

BrightPath Biotherapeutics Co., Ltd. engages in the development of cancer immunotherapy drugs in Japan. The company is developing BP2201, a product candidate in Phase I clinical trials to target cancer antigens in various types of cancer; BP2202, Phase I clinical trial to target cancer; and BP2301, a product candidate in Phase I clinical trials for the treatment of solid tumors sarcoma and gynecological cancers. In addition, its product candidates in preclinical trials include BP1200 that targets CD73; BP1202 that targets acute myeloid leukemia; BP1210, which suppresses T cell cytotoxicity; BP1212 to inhibit TIM-3 and CD39; BP1209 to target tumor-specific neo-antigens; and BP1223 to target blood cancers. The company was formerly known as GreenPeptide Co., Ltd. and changed its name to BrightPath Biotherapeutics Co., Ltd. in July 2017. The company was incorporated in 2003 and is headquartered in Kawasaki, Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
11.99M8.64%455.79M
Public Companies & Retail Investors
126.90M91.36%4.82B
Total
138.89M100.00%5.28B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rakuten Investment Management, Inc.3.18%4,413,400167,709
BNP Paribas Financial Markets SNC1.31%1,826,40069,403

FAQ

What Is the BrightPath Biotherapeutics (4594) Stock Price Today?

The BrightPath Biotherapeutics stock price today is 39.0 JPY.

What Stock Exchange Does BrightPath Biotherapeutics Trade On?

BrightPath Biotherapeutics is listed and trades on the Tokyo Stock Exchange.

What Is the Stock Symbol for BrightPath Biotherapeutics?

The stock symbol for BrightPath Biotherapeutics is "4594."

What Is the BrightPath Biotherapeutics Market Cap?

As of today, BrightPath Biotherapeutics market cap is 5.42B JPY.

What Is BrightPath Biotherapeutics's Earnings Per Share (TTM)?

The BrightPath Biotherapeutics EPS (TTM) is -11.70.

When Is the Next BrightPath Biotherapeutics Earnings Date?

BrightPath Biotherapeutics will release its next earnings report on Feb 05, 2027.

From a Technical Analysis Perspective, Is 4594 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has BrightPath Biotherapeutics Stock Split?

BrightPath Biotherapeutics has split 0 times.

How Many Employees Does BrightPath Biotherapeutics Have?

BrightPath Biotherapeutics has 42 employees.

What is the current trading status of BrightPath Biotherapeutics (4594)?

As of Nov 17, 2026, BrightPath Biotherapeutics (4594) is trading at a price of 39.0 JPY, with a previous close of 38.0 JPY. The stock has fluctuated within a day range of 37.0 JPY to 39.0 JPY, while its 52-week range spans from 36.0 JPY to 96.0 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.